Short answer
Aura Biosciences, Inc. (AURA) filed an 8-K current report with the SEC on May 4, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events). Forward-looking disclosure tied to proposed equity offering and stock repurchase.
Aura Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Forward-looking disclosure tied to proposed equity offering and stock repurchase
- Completion remains subject to market conditions and customary closing conditions
- Equity offering proceeds intended to fund the stock repurchase
- Investors face execution risk and potential deviation from anticipated transaction terms
Item 8.01 · Other Events
- Signature page only, dated May 4, 2026, signed by Anthony Gibney
- Gibney identified as Chief Financial and Business Officer and Principal Financial Officer
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Aura Biosciences, Inc. 8-K filings
Get the next AURA 8-K as it lands
Follow AURA for push alerts, or ask the research agent what this filing means.